Real-World Outcomes of Subsequent Chemotherapy after Progression Following Chemoradiation and Consolidative Durvalumab Therapy in Locally Advanced Non-small Cell Lung Cancer: An Exploratory Analysis from the CRIMSON Study (HOPE-005)
Year: 2024
Type: article
Source: Clinical Lung Cancer
Authors: Hayato Kawachi, Motohiro Tamiya, Yuko Oya, Go Saito, Yoshihiko Taniguchi, Hirotaka Matsumoto, Yuki Sato, Taiichiro Otsuki, Hidekazu Suzuki, Yasushi Fukuda, Satoshi Tanaka, Yoko Tsukita, Junji Uchida, Yoshihiko Sakata, Yuki Nakatani, Ryota Shibaki, Daisuke Arai, Asuka Okada, Satoshi Hara, Koichi Takayama, Kazumi Nishino
Institutions: Kyoto Prefectural University of Medicine, Osaka International Cancer Institute, Fujita Health University, Aichi Cancer Center Hospital, Chiba University, NHO Kinki Chuo Chest Medical Center, Hyogo Prefectural Amagasaki General Medical Center, Kobe City Medical Center General Hospital, Hyogo Medical University, Osaka Habikino Medical Center, Kurashiki Central Hospital, Osaka Prefectural Medical Center, Tohoku University Hospital, Toneyama National Hospital, National Hospital Organization, Saiseikai Kumamoto Hospital, Osaka City General Hospital, Wakayama Medical University, Saiseikai Utsunomiya hospital, Saiseikai Suita Hospital, Itami City Hospital
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4401022110